• 1. An amide probe as a selective Al3+ and Fe3+ sensor inside the HeLa and a549 cell lines: Pictet–Spengler reaction for the rapid detection of tryptophan amino acid?
  Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
• 2. An aquatic host–guest complex between a supramolecular G-quadruplex and the anticancer drug doxorubicin?
  José M. Rivera,Mariana Martín-Hidalgo,Jean C. Rivera-Ríos Org. Biomol. Chem., 2012,10, 7562-7565
• 3. Alt-proteins: A promising future
• 4. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 5. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzopyrazoles Indazoles

Recent Advances in the Study of 4-chloro-1-methyl-1H-indazole-3-carbaldehyde (CAS: 1033693-09-2)

4-chloro-1-methyl-1H-indazole-3-carbaldehyde (CAS: 1033693-09-2) is a key intermediate in the synthesis of various biologically active compounds, particularly in the development of kinase inhibitors and other therapeutic agents. Recent studies have highlighted its significance in medicinal chemistry due to its versatile reactivity and potential applications in drug discovery. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential therapeutic applications.

In a recent study published in the Journal of Medicinal Chemistry, researchers explored the use of 4-chloro-1-methyl-1H-indazole-3-carbaldehyde as a precursor for the synthesis of novel indazole-based kinase inhibitors. The study demonstrated that this compound could be efficiently functionalized to yield derivatives with potent inhibitory activity against specific kinases implicated in cancer and inflammatory diseases. The authors reported a high-yield synthetic route and characterized the resulting compounds using NMR and mass spectrometry, confirming their structural integrity and purity.

Another significant development was reported in a Bioorganic & Medicinal Chemistry Letters article, where 4-chloro-1-methyl-1H-indazole-3-carbaldehyde was utilized in the design of small-molecule modulators for a specific protein-protein interaction (PPI) target. The study emphasized the compound's role in enhancing binding affinity and selectivity, which are critical for developing targeted therapies. Computational modeling and in vitro assays were employed to validate the interactions, providing insights into the structural requirements for optimal activity.

Further research has also investigated the compound's potential in antimicrobial applications. A recent preprint on ChemRxiv described the synthesis of indazole derivatives from 4-chloro-1-methyl-1H-indazole-3-carbaldehyde, which exhibited promising activity against drug-resistant bacterial strains. The study highlighted the importance of the chloro and aldehyde functional groups in mediating these effects, suggesting a potential avenue for developing new antibiotics.

In summary, 4-chloro-1-methyl-1H-indazole-3-carbaldehyde (CAS: 1033693-09-2) continues to be a valuable building block in medicinal chemistry, with recent studies underscoring its utility in kinase inhibitor development, PPI modulation, and antimicrobial drug discovery. Future research is expected to further explore its applications, particularly in addressing unmet medical needs in oncology and infectious diseases.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)